SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SCLX Stock Acquisition JV LLC(33. 3%)
Scilex Holding | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Ma Stephen Hoi
Scilex Holding | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SCLX Stock Acquisition JV LLC(36.4%)
Scilex Holding | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SCLX Stock Acquisition JV LLC(38.2%)
Scilex Holding | 4: Statement of changes in beneficial ownership of securities-Officer Ji Henry
Scilex Holding | 4: Statement of changes in beneficial ownership of securities-Officer SHAH JAISIM
Scilex Holding | 4: Statement of changes in beneficial ownership of securities-Director Wu Yue Alexander
Scilex Holding | 4: Statement of changes in beneficial ownership of securities-Director Chun Jay
Scilex Holding | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Ma Stephen Hoi
Scilex Holding | D: Filing D
Scilex Holding | 3: Initial statement of beneficial ownership of securities-Officer Ji Henry
Scilex Holding | SC 13D: Statement of acquisition of beneficial ownership by individuals-SCLX Stock Acquisition JV LLC(39.3%)
Scilex Holding | 3: Initial statement of beneficial ownership of securities-10% Owner SCLX Stock Acquisition JV LLC
Scilex Holding | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(1.3%)
Scilex Holding | 3: Initial statement of beneficial ownership of securities-Director Wu Yue Alexander
Scilex Holding | 3: Initial statement of beneficial ownership of securities-Director Chun Jay
Scilex Holding | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Ma Stephen Hoi
Scilex Holding | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.
Scilex Holding | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(43.3%)
Scilex Holding | 4: Statement of changes in beneficial ownership of securities-Officer Ji Henry
No Data